May 8, 2018 / 8:54 PM / 16 days ago

BRIEF-Five Prime Therapeutics Reports Q1 Loss Per Share $0.63

May 8 (Reuters) - Five Prime Therapeutics Inc:

* FIVE PRIME THERAPEUTICS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS

* Q1 LOSS PER SHARE $0.63

* Q1 EARNINGS PER SHARE VIEW $-0.55 — THOMSON REUTERS I/B/E/S

* EXPECTS FULL-YEAR 2018 NET CASH USED IN OPERATING ACTIVITIES TO BE LESS THAN $135 MILLION

* ESTIMATES ENDING 2018 WITH APPROXIMATELY $250 MILLION IN CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below